Drawing for NEUROSTAT

USPTO serial 85555773

NEUROSTAT

Reviewed by CopyMark Law Group

Reg. 4347704Status 800Registered
Filing date
Status date
Registration date
Jun 4, 2013
Examiner
LE, KHANH M
Law office
Historical data usage

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with NEUROSTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Chesal

Michael B. Chesal Peretz Chesal & Herrmann, P.L.1 S.E. 3rd Avenue, Suite 1820SunTrust International CenterMiami, FL 33131

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 7, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jun 18, 2026C.7CNEW CERTIFICATE UNDER SECTION 7 - PROCESSED—
Jun 11, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 1, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 29, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Nov 14, 2023NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Nov 14, 2023RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Nov 14, 202389AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Nov 8, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 15, 2023E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 26, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 4, 2022REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 18, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Dec 18, 20198.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Dec 6, 2019EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jun 14, 2019PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Jun 14, 2019XXXXPOST REGISTRATION ACTION CORRECTION—
Jun 13, 2019PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Jun 12, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2019ES8RTEAS SECTION 8 RECEIVED—
Jun 4, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 4, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2013SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 27, 2013REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 26, 2013ALIEASSIGNED TO LIE—
Apr 15, 2013CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 29, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 28, 2013SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 28, 2013EX1GSOU EXTENSION 1 GRANTED—
Mar 27, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 11, 2013IUAFUSE AMENDMENT FILED—
Mar 11, 2013EXT1SOU EXTENSION 1 FILED—
Mar 11, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2013EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 11, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 17, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 17, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 27, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 11, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 11, 2012DOCKASSIGNED TO EXAMINER—
Mar 7, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance